| 4 | Gut and liver involvement in pediatric hematolymphoid malignancies显示文摘Hematolymphoid malignancies are common neoplasms in childhood.The involvement of the gastrointestinal(GI)tract,liver,biliary system,pancreas,and peritoneum are closely interlinked and commonly encountered.In leukemias,lymphomas,and Langerhans cell histiocytosis(LCH),the manifestations result from infiltration,compression,overwhelmed immune system,and chemotherapyinduced drug toxicities.In acute leukemias,major manifestations are infiltrative hepatitis,drug induced gastritis,neutropenic typhlitis and chemotherapy related pancreatitis.Chronic leukemias are rare.Additional presentation in lymphomas is cholestasis due to infiltration or biliary obstruction by lymph nodal masses.Presence of ascites needs a thorough workup for the underlying pathophysiology that may modify the therapy and affect the outcome.Uncommon hematolymphoid malignancies are primary hepatic,hepatosplenic,and GI lymphomas which have strict definitions.In advanced diseases with extensive spread,it may be impossible to distinguish these diseases from the primary site of origin.LCH produces biliary strictures that mimic as sclerosing cholangitis.Liver infiltration is associated with poor liver recovery even after chemotherapy.The heterogeneity of gut and liver manifestations in hematolymphoid malignancies has a clinical impact on their management.Though chemotherapy is the mainstay of therapy in all hematolymphoid malignancies,debulking surgery and radiotherapy have an adjuvant role in specific clinical scenarios.Rare situations presenting as liver failure or end-stage liver disease require liver transplantation.At their initial presentation to a primary care physician,given the ambiguity in clinical manifestations and the prognostic difference with time-bound management,it is vital to recognize them early for optimal outcomes.Pooled data from robust registries across the world is required for better understanding of these complications. | Umeshreddy V Devarapalli Moinak S Sarma Gopinathan Mathiyazhagan | 2022 | World Journal of Gastrointestinal Oncology2022，14，3： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员